MedPath

Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis Contacts

Not Applicable
Completed
Conditions
Latent Tuberculosis
Interventions
Radiation: Ultralow dose chest CT scan
Registration Number
NCT02454738
Lead Sponsor
Seoul National University Hospital
Brief Summary

To evaluate CT abnormalities in the lung parenchyma in close contacts at high risk for developing multidrug- or extensively drug-resistant Tb by using a follow-up ultralow dose CT scan.

Detailed Description

Multidrug- or extensively resistant tuberculosis tuberculosis is a major public health threat worldwide and the global burden of drug-resistant tuberculosis is increasing. Drug-resistant tuberculosis is associated with long period and high costs for treatment, high rates of default, treatment failure and death.

Drug-resistant tuberculosis should be diagnosed rapidly so as to reduce potential transmission. In the United States, at least one-fifths cases of multidrug-resistant tuberculosis can be linked to transmission. Close contacts to drug-resistant tuberculosis are at high risk for being transmitted and developing drug-resistant tuberculosis. There are two options suggested for close contacts to drug-resistant tuberculosis: preventive therapy and close observation. But both strategies are lack of sufficient evidence.

Ultralow chest CT scan may be an alternative for early identification and risk stratification of developing active tuberculosis in close contacts to drug-resistant tuberculosis with minimal radiation exposure similar to that of chest x-ray.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
6
Inclusion Criteria
  • Individuals who had household contact with or who had worked in the same rooms as patients with smear-positive, culture-proven multidrug-or extensively drug-resistant pulmonary tuberculosis for longer than 8 hours per day
  • Older than 20 years
Read More
Exclusion Criteria
  • Pregnant women
  • Individuals with abnormality on chest x-ray suspected of active tuberculosis
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Chest CT scanUltralow dose chest CT scanTwo follow-up ultralow dose chest CT scans will be taken 3 months and 1 year after the initial ultralow dose chest CT scan in close contact at high risk for developing multidrug- or extensively drug-resistant tuberculosis.
Primary Outcome Measures
NameTimeMethod
Interval change of CT abnormalities potentially suggesting active tuberculosis in the lung parenchyma during the follow-up.3 months and 1 year after the initial CT scanning
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Seoul National University Hospital

🇰🇷

Seoul, Jongno-gu, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath